Rigel Pharmaceuticals
RIGL
RIGL
123 hedge funds and large institutions have $250M invested in Rigel Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
1% more funds holding
Funds holding: 122 → 123 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
123
Holding in Top 10
1
Calls
$643K
Puts
$348K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$6.55M | |
| 3 | +$4.61M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.81M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.39M |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$1.93M | |
| 3 | -$1.77M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.44M |
| 5 |
Millennium Management
New York
|
-$1.18M |
